文献速递多重用药老年综合评估

社区老年人潜在不适当用药与全因死亡风险的前瞻性研究

A Prospective Study on Potentially Inappropriate Drug Use and All-Cause Mortality in Community-Dwelling Older Adults.
PubMed 文献 · J Am Geriatr Soc · 2025-08-11

结果显示PIP普遍存在,暴露于≥2种PIM或≥2项PPO与全因死亡及非癌死亡风险升高相关。

要点

  • 81.2%的参与者存在至少1项潜在不适当用药问题
  • ≥2种PIM与全因死亡风险升高相关(Beers HR=1.31;STOPP HR=1.25)
  • ≥2项PPO与全因死亡风险升高1.84倍相关,男性中关联更强

核心结论

  • 社区老年人中潜在不适当用药普遍存在,并与长期全因死亡及非癌死亡风险升高相关。
  • 在自评健康为「极好/好」的老年人中,Beers标准PIM与死亡的关联强于自评健康「差/极差」者。
  • PPO与全因死亡的关联在男性中更强,提示需要性别特异性的用药指南。

研究设计与样本

  • 使用2023 Beers标准及STOPP/START v3标准识别PIM和PPO。
  • 采用Cox比例风险模型和Fine-Gray亚分布风险模型,分别评估全因死亡和非癌死亡关联,并调整社会人口学、生活方式和健康相关因素。

主要发现

  • 81.2%的参与者暴露于>1项潜在不适当用药问题;按Beers和STOPP标准分别有52.6%和45.0%暴露于PIM,59.3%暴露于PPO。
  • 暴露于≥2种PIM与全因死亡风险升高相关:Beers标准HR=1.31(95% CI: 1.04-1.69),STOPP标准HR=1.25(95% CI: 1.00-1.55)。
  • PIM(Beers标准)与自评健康的交互作用有统计学意义(p-for-interaction=0.030),自评健康「极好/好」者关联更强。
  • ≥2种PIM与两种工具下的非癌死亡风险升高约1.4倍相关。
  • ≥2项PPO与全因死亡风险升高1.84倍相关(HR=1.84,95% CI: 1.24-2.72),男性中关联更强(p-for-interaction=0.012);暴露1项或≥2项PPO分别与非癌死亡风险升高1.3倍和2.0倍相关。

关键数值与推荐

  • PIM识别采用2023 Beers标准和STOPP/START v3标准。
  • 暴露于≥2种PIM与全因死亡的HR:Beers 1.31(95% CI: 1.04-1.69),STOPP 1.25(95% CI: 1.00-1.55)。
  • 暴露于≥2项PPO与全因死亡的HR=1.84(95% CI: 1.24-2.72)。
  • PIM(Beers标准)与自评健康交互作用p=0.030,PPO与性别交互作用p=0.012。

临床怎么用

  • 在社区老年人长期管理中应常规筛查PIM和PPO,尤其关注≥2种PIM或≥2项PPO者。
  • 对自评健康较好的老年人也应重视PIM问题,不应因主观健康良好而放松用药审查。
  • 处方审核中应同时评估处方遗漏(PPO),并考虑性别差异对用药风险的影响。

局限性

  • 原文摘要未报告局限性内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Potentially inappropriate prescribing (PIP), encompassing potentially inappropriate medications (PIMs) and prescribing omissions (PPOs), is prevalent among older adults and consistently associated with adverse health outcomes. However, evidence on its impact on mortality remains limited. We examined the associations of PIMs and PPOs with long-term mortality in a cohort of community-dwelling older adults. METHODS: One thousand two hundred and ten participants from the third follow-up (1999-2007) of a longitudinal prospective cohort study were followed for mortality until 03/2022. PIMs and PPOs were identified using the 2023 Beers and the Screening Tool of Older Persons' Potentially Inappropriate Prescriptions/Screening Tool to Alert doctors to Right Treatment (STOPP/START) v3 criteria. Cox proportional hazards and Fine-Gray subdistribution hazard models assessed associations between PIP and all-cause and non-cancer mortality, respectively, adjusting for sociodemographic, lifestyle, and health-related factors. RESULTS: Overall, 81.2% of participants were exposed to > 1 problem: 52.6% and 45.0% to PIMs based on Beers and STOPP criteria, respectively, and 59.3% to PPOs. In multivariable analysis, exposure to ≥ 2 PIMs was associated with increased all-cause mortality for Beers (HR = 1.31, 95% CI: 1.04-1.69) and STOPP (HR = 1.25, 95% CI: 1.00-1.55) criteria. An interaction between PIMs (Beers criteria) and self-rated health (SRH) indicated stronger associations for those with "excellent/good" baseline SRH, compared to those with "poor/very poor" SRH (p-for-interaction = 0.030). Use of ≥ 2 PIMs was also associated with a 1.4-fold increased non-cancer mortality risk for both tools. Exposure to ≥ 2 PPOs was associated with a 1.8-fold increase in all-cause mortality risk (HR = 1.84, 95% CI: 1.24-2.72), while associations were stronger in men (p-for-interaction = 0.012). Exposure to 1 or ≥ 2 PPOs was also associated with 1.3 and 2.0-fold increased non-cancer mortality risk, respectively. CONCLUSIONS: PIP is prevalent and is associated with increased long-term mortality among community-dwelling older adults. Addressing PIMs in healthier older individuals and reducing PPOs in clinical practice is critical. Sex-specific pharmaceutical guidelines are warranted.

来源:J Am Geriatr Soc,查看原文。版权归原作者所有。

引用

  1. Orenstein L, Chetrit A, Laufer K, et al. A Prospective Study on Potentially Inappropriate Drug Use and All-Cause Mortality in Community-Dwelling Older Adults. J Am Geriatr Soc. 2025. PMID: 40785370. doi:10.1111/jgs.70002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。